SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014
Two- and Four-year CD Rates Rise Following European Central Bank Interest Rate Cuts
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Galectin Therapeutics, Inc. and Certain Officers - GALT
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Galectin Therapeutics Inc. To Contact Brower Piven Before The September 29, 2014 Lead Plaintiff Deadline In Class Action Lawsuit
Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Galectin Therapeutics Inc.
National Averages Of CD Rates Unchanged As Investors Await Further Insight
Elyse Foster has learned that clients need a confident hand guiding them in times of trouble.
Two advisors take different approaches in their portfolios to achieve the same goals: low risk and stability.